Clinical trial · Observational
Indications and Outcomes in Kidney-ureteral Pediatric Lithiasis: Experience of Parma
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Incidence of paediatric urolithiasis is increasing in Europe and North America. Nowadays the management of stone disease is a common practice in not endemic country. The surgical's treatment is based on similar techniques as for adults. In the last years due to miniaturization of endoscopic instruments endourology has become the best approach to treat urinary stones in children. The investigators have retrospectively reviewed experience from 01/01/2000 to 28/02/2019 in children ≤ 16 years old affected by urinary stones who underwent rigid and flexible ureterorenoscopy and pecutaneous nephrolitotripsy procedures and recorded clinical data, overall success rate and complication.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Pediatric ALL | Childhood Acute Lymphoblastic Leukemia | ALIAS | 0.90 |
| Stone, Urinary | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (4)
- measure
- stone free rate
- timeFrame
- immediately
- description
- no stones or residual fragment \< 4 mm
- measure
- stone free rate
- timeFrame
- 3 months follow up
- description
- no stones or residual fragment \< 4 mm
- measure
- complication rate
- timeFrame
- immediately
- description
- clavien-dindo classification
- measure
- complication rate
- timeFrame
- 3 months follow up
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 0 Years
- Maximum age
- 17 Years
Show eligibility criteria text
Inclusion Criteria: * 0-17 yrs old, urinary stones (kidney, ureteral, not bladder), with or without malformations or metabolic diseases Exclusion Criteria: * none
References
Publications (0)
Data not yet available